{"transactions":[{"id":699404,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-08-03T13:32:27.000Z","date":"2026-07-31","kind":"exercise","planned":false,"acquired":false,"shares":34789,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."}],"balance_after":347886,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":34789},"source":{"system":"sec-edgar","filing":"0001193125-26-329694","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526329694/ownership.xml","form_type":"4"}},{"id":699403,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-08-03T13:32:27.000Z","date":"2026-07-30","kind":"exercise","planned":false,"acquired":false,"shares":50021,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 800,337 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant. The full amount of the RSUs granted to the Reporting Person is reflected herein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 800,337 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant. The full amount of the RSUs granted to the Reporting Person is reflected herein."}],"balance_after":700295,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":50021},"source":{"system":"sec-edgar","filing":"0001193125-26-329694","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526329694/ownership.xml","form_type":"4"}},{"id":699402,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-03T13:32:27.000Z","date":"2026-07-31","kind":"exercise","planned":false,"acquired":true,"shares":34789,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":856492,"source":{"system":"sec-edgar","filing":"0001193125-26-329694","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526329694/ownership.xml","form_type":"4"}},{"id":699401,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-03T13:32:27.000Z","date":"2026-07-30","kind":"exercise","planned":false,"acquired":true,"shares":50021,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":821703,"source":{"system":"sec-edgar","filing":"0001193125-26-329694","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526329694/ownership.xml","form_type":"4"}},{"id":706068,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-07-20T20:22:52.000Z","date":"2026-07-19","kind":"exercise","planned":false,"acquired":false,"shares":13797,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":82781,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":13797},"source":{"system":"sec-edgar","filing":"0001193125-26-308958","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526308958/ownership.xml","form_type":"4"}},{"id":706067,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-20T20:22:52.000Z","date":"2026-07-19","kind":"exercise","planned":false,"acquired":true,"shares":13797,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":771682,"source":{"system":"sec-edgar","filing":"0001193125-26-308958","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526308958/ownership.xml","form_type":"4"}},{"id":726425,"issuer":{"id":6184,"kind":"organization","name":"TerrAscend Corp."},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Share Option (Right to Buy)","published_at":"2026-06-25T23:09:59.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":150000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"See remarks."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"See remarks."}],"balance_after":150000,"derivative":{"exercise_price":0.26,"expiration_date":"2029-04-24","underlying":"Common Shares","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0002064832-26-000248","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1778129/000206483226000248/form4.xml","form_type":"4"}},{"id":726424,"issuer":{"id":6184,"kind":"organization","name":"TerrAscend Corp."},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Share Option (Right to Buy)","published_at":"2026-06-25T23:09:59.000Z","date":"2026-06-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":150000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"See remarks."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"See remarks."}],"balance_after":0,"derivative":{"exercise_price":6.44,"expiration_date":"2029-04-24","underlying":"Common Shares","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0002064832-26-000248","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778129/000206483226000248/form4.xml","form_type":"4"}},{"id":794646,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-05-04T15:30:39.000Z","date":"2026-04-30","kind":"exercise","planned":false,"acquired":false,"shares":50021,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 800,337 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 800,337 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant."}],"balance_after":750316,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":50021},"source":{"system":"sec-edgar","filing":"0001193125-26-203196","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526203196/ownership.xml","form_type":"4"}},{"id":794645,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-05-04T15:30:39.000Z","date":"2026-04-30","kind":"exercise","planned":false,"acquired":false,"shares":34789,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."}],"balance_after":382675,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":34789},"source":{"system":"sec-edgar","filing":"0001193125-26-203196","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526203196/ownership.xml","form_type":"4"}},{"id":794644,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-04T15:30:39.000Z","date":"2026-04-30","kind":"exercise","planned":false,"acquired":true,"shares":50021,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 11,023 shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 30, 2026."}],"balance_after":757885,"source":{"system":"sec-edgar","filing":"0001193125-26-203196","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526203196/ownership.xml","form_type":"4"}},{"id":794643,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-04T15:30:39.000Z","date":"2026-04-30","kind":"exercise","planned":false,"acquired":true,"shares":34789,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":696841,"source":{"system":"sec-edgar","filing":"0001193125-26-203196","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526203196/ownership.xml","form_type":"4"}},{"id":804001,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-04-21T13:41:20.000Z","date":"2026-04-19","kind":"exercise","planned":false,"acquired":false,"shares":13797,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":96758,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":13797},"source":{"system":"sec-edgar","filing":"0001193125-26-165365","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526165365/ownership.xml","form_type":"4"}},{"id":804000,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-21T13:41:20.000Z","date":"2026-04-19","kind":"exercise","planned":false,"acquired":true,"shares":13797,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":662052,"source":{"system":"sec-edgar","filing":"0001193125-26-165365","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526165365/ownership.xml","form_type":"4"}},{"id":814999,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-04-06T23:06:11.000Z","date":"2026-04-03","kind":"exercise","planned":false,"acquired":false,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning one year after the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning one year after the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date."}],"balance_after":62500,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001193125-26-144196","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526144196/ownership.xml","form_type":"4"}},{"id":814998,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-06T23:06:11.000Z","date":"2026-04-03","kind":"exercise","planned":false,"acquired":true,"shares":62500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 14,045 shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 30, 2025."}],"balance_after":648255,"source":{"system":"sec-edgar","filing":"0001193125-26-144196","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526144196/ownership.xml","form_type":"4"}},{"id":923416,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance Stock Units","published_at":"2026-02-03T15:00:14.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":800336,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Performance stock units (\"PSUs\") convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On January 30, 2026, the Reporting Person was granted 800,336 PSUs which vest upon the following time-based vesting schedule: the PSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant, subject to satisfaction of the milestone-based vesting condition: the applicable percentage of the PSUs vesting based on a net product sales revenue target for the fiscal year ending December 31, 2026 as reported in the Issuer's Form 10-K. The full amount of the PSUs granted to the Reporting Person is reflected herein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On January 30, 2026, the Reporting Person was granted 800,336 PSUs which vest upon the following time-based vesting schedule: the PSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant, subject to satisfaction of the milestone-based vesting condition: the applicable percentage of the PSUs vesting based on a net product sales revenue target for the fiscal year ending December 31, 2026 as reported in the Issuer's Form 10-K. The full amount of the PSUs granted to the Reporting Person is reflected herein."}],"balance_after":800336,"derivative":{"underlying":"Common Stock","underlying_shares":800336},"source":{"system":"sec-edgar","filing":"0001193125-26-034633","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526034633/ownership.xml","form_type":"4"}},{"id":923415,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T15:00:14.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":800337,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 800,337 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant. The full amount of the RSUs granted to the Reporting Person is reflected herein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 800,337 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant. The full amount of the RSUs granted to the Reporting Person is reflected herein."}],"balance_after":800337,"derivative":{"underlying":"Common Stock","underlying_shares":800337},"source":{"system":"sec-edgar","filing":"0001193125-26-034633","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526034633/ownership.xml","form_type":"4"}},{"id":923398,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T13:30:06.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":false,"shares":34789,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."}],"balance_after":417464,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":34789},"source":{"system":"sec-edgar","filing":"0001193125-26-034490","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526034490/ownership.xml","form_type":"4"}},{"id":923397,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-02-03T13:30:06.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":true,"shares":34789,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":571710,"source":{"system":"sec-edgar","filing":"0001193125-26-034490","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526034490/ownership.xml","form_type":"4"}},{"id":936479,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-01-20T19:39:00.000Z","date":"2026-01-19","kind":"exercise","planned":false,"acquired":false,"shares":13797,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":110375,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":13797},"source":{"system":"sec-edgar","filing":"0001193125-26-016413","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526016413/ownership.xml","form_type":"4"}},{"id":936478,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-20T19:39:00.000Z","date":"2026-01-19","kind":"exercise","planned":false,"acquired":true,"shares":13797,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":536921,"source":{"system":"sec-edgar","filing":"0001193125-26-016413","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526016413/ownership.xml","form_type":"4"}},{"id":1008958,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-11-04T17:31:27.000Z","date":"2025-10-31","kind":"exercise","planned":false,"acquired":false,"shares":34789,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."}],"balance_after":452253,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":34789},"source":{"system":"sec-edgar","filing":"0001193125-25-264032","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312525264032/ownership.xml","form_type":"4"}},{"id":1008957,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-11-04T17:31:27.000Z","date":"2025-10-31","kind":"exercise","planned":false,"acquired":true,"shares":34789,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":523124,"source":{"system":"sec-edgar","filing":"0001193125-25-264032","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312525264032/ownership.xml","form_type":"4"}},{"id":1015578,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-10-21T15:23:26.000Z","date":"2025-10-19","kind":"exercise","planned":false,"acquired":false,"shares":13797,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":124172,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":13797},"source":{"system":"sec-edgar","filing":"0001193125-25-244520","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312525244520/ownership.xml","form_type":"4"}},{"id":1015577,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-21T15:23:26.000Z","date":"2025-10-19","kind":"exercise","planned":false,"acquired":true,"shares":13797,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":488335,"source":{"system":"sec-edgar","filing":"0001193125-25-244520","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312525244520/ownership.xml","form_type":"4"}},{"id":1077022,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-08-04T21:21:12.000Z","date":"2025-07-31","kind":"exercise","planned":false,"acquired":false,"shares":34789,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."}],"balance_after":487042,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":34789},"source":{"system":"sec-edgar","filing":"0000950170-25-102150","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025102150/ownership.xml","form_type":"4"}},{"id":1077021,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-08-04T21:21:12.000Z","date":"2025-07-31","kind":"exercise","planned":false,"acquired":true,"shares":34789,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":474538,"source":{"system":"sec-edgar","filing":"0000950170-25-102150","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025102150/ownership.xml","form_type":"4"}},{"id":1083663,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-07-22T15:55:43.000Z","date":"2025-07-19","kind":"exercise","planned":false,"acquired":false,"shares":13797,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":137969,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":13797},"source":{"system":"sec-edgar","filing":"0000950170-25-097488","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025097488/ownership.xml","form_type":"4"}},{"id":1083662,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-07-22T15:55:43.000Z","date":"2025-07-19","kind":"exercise","planned":false,"acquired":true,"shares":13797,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":439749,"source":{"system":"sec-edgar","filing":"0000950170-25-097488","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025097488/ownership.xml","form_type":"4"}},{"id":1101736,"issuer":{"id":6184,"kind":"organization","name":"TerrAscend Corp."},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-06-25T20:57:15.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":433653,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a restricted share unit (\"RSU\") award for service as a director of the Issuer. The shares underlying the RSUs will vest in full on December 31, 2025, subject to the Reporting Person's continuous service with the Issuer as of the vesting date."}],"balance_after":1076538,"source":{"system":"sec-edgar","filing":"0001415889-25-018197","document":"form4-06252025_080612.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778129/000141588925018197/form4-06252025_080612.xml","form_type":"4"}},{"id":1161884,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-05-03T00:23:21.000Z","date":"2025-04-30","kind":"exercise","planned":false,"acquired":false,"shares":34789,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."}],"balance_after":521831,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":34789},"source":{"system":"sec-edgar","filing":"0000950170-25-063061","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025063061/ownership.xml","form_type":"4"}},{"id":1161883,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-05-03T00:23:21.000Z","date":"2025-04-30","kind":"exercise","planned":false,"acquired":true,"shares":34789,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":425952,"source":{"system":"sec-edgar","filing":"0000950170-25-063061","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025063061/ownership.xml","form_type":"4"}},{"id":1167999,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-04-22T13:39:26.000Z","date":"2025-04-19","kind":"exercise","planned":false,"acquired":false,"shares":13796,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":151766,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":13796},"source":{"system":"sec-edgar","filing":"0000950170-25-056488","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025056488/ownership.xml","form_type":"4"}},{"id":1167998,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-04-22T13:39:26.000Z","date":"2025-04-19","kind":"exercise","planned":false,"acquired":true,"shares":13796,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":391163,"source":{"system":"sec-edgar","filing":"0000950170-25-056488","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025056488/ownership.xml","form_type":"4"}},{"id":1181418,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-04-03T21:48:40.000Z","date":"2025-04-03","kind":"exercise","planned":false,"acquired":false,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning one year after the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning one year after the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date."}],"balance_after":125000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0000950170-25-050677","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025050677/ownership.xml","form_type":"4"}},{"id":1181417,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-04-03T21:48:40.000Z","date":"2025-04-03","kind":"exercise","planned":false,"acquired":true,"shares":62500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":377367,"source":{"system":"sec-edgar","filing":"0000950170-25-050677","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025050677/ownership.xml","form_type":"4"}},{"id":1190974,"issuer":{"id":6184,"kind":"organization","name":"TerrAscend Corp."},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-03-26T21:06:32.000Z","date":"2025-03-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":2258,"price":0.46,"value":1038.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted share units pursuant to an equity plan administered by the Issuer."}],"balance_after":642885,"source":{"system":"sec-edgar","filing":"0001415889-25-009042","document":"form4-03262025_090328.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778129/000141588925009042/form4-03262025_090328.xml","form_type":"4"}},{"id":1286292,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-02-04T17:43:47.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":556620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."}],"balance_after":556620,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":556620},"source":{"system":"sec-edgar","filing":"0000950170-25-013042","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025013042/ownership.xml","form_type":"4"}},{"id":1286291,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-02-04T17:43:47.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":1113240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant (January 31, 2025)."}],"balance_after":1113240,"derivative":{"exercise_price":1.7,"expiration_date":"2035-01-31","underlying":"Common Stock","underlying_shares":1113240},"source":{"system":"sec-edgar","filing":"0000950170-25-013042","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025013042/ownership.xml","form_type":"4"}},{"id":1298288,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-01-22T14:06:51.000Z","date":"2025-01-19","kind":"exercise","planned":false,"acquired":false,"shares":13797,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":165562,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":13797},"source":{"system":"sec-edgar","filing":"0000950170-25-007545","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025007545/ownership.xml","form_type":"4"}},{"id":1298287,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-01-22T14:06:51.000Z","date":"2025-01-19","kind":"exercise","planned":false,"acquired":true,"shares":13797,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 10,683 shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on October 31, 2024."}],"balance_after":314867,"source":{"system":"sec-edgar","filing":"0000950170-25-007545","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025007545/ownership.xml","form_type":"4"}},{"id":1315000,"issuer":{"id":6184,"kind":"organization","name":"TerrAscend Corp."},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-01-03T21:05:29.000Z","date":"2024-12-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":71704,"price":0.65,"value":46607.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted share units pursuant to an equity plan administered by the Issuer."}],"balance_after":645143,"source":{"system":"sec-edgar","filing":"0001415889-25-000386","document":"form4-01032025_090124.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778129/000141588925000386/form4-01032025_090124.xml","form_type":"4"}},{"id":1383782,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2024-10-21T19:49:55.000Z","date":"2024-10-19","kind":"exercise","planned":false,"acquired":false,"shares":13797,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":179359,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":13797},"source":{"system":"sec-edgar","filing":"0000950170-24-115920","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017024115920/ownership.xml","form_type":"4"}},{"id":1383781,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-10-21T19:49:55.000Z","date":"2024-10-19","kind":"exercise","planned":false,"acquired":true,"shares":13797,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":290387,"source":{"system":"sec-edgar","filing":"0000950170-24-115920","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017024115920/ownership.xml","form_type":"4"}},{"id":1450773,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2024-07-22T13:54:19.000Z","date":"2024-07-19","kind":"exercise","planned":false,"acquired":false,"shares":13797,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":193156,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":13797},"source":{"system":"sec-edgar","filing":"0000950170-24-085096","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017024085096/ownership.xml","form_type":"4"}},{"id":1450772,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-07-22T13:54:19.000Z","date":"2024-07-19","kind":"exercise","planned":false,"acquired":true,"shares":13797,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":276590,"source":{"system":"sec-edgar","filing":"0000950170-24-085096","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017024085096/ownership.xml","form_type":"4"}},{"id":1473266,"issuer":{"id":6184,"kind":"organization","name":"TerrAscend Corp."},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2024-06-20T21:30:17.000Z","date":"2024-06-17","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on April 24, 2019, and is fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on April 24, 2019, and is fully vested."}],"balance_after":150000,"derivative":{"exercise_price":6.44,"expiration_date":"2029-04-24","underlying":"Common Shares","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001415889-24-017691","document":"form4-06202024_050614.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1778129/000141588924017691/form4-06202024_050614.xml","form_type":"4"}},{"id":1473265,"issuer":{"id":6184,"kind":"organization","name":"TerrAscend Corp."},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2024-06-20T21:30:17.000Z","date":"2024-06-17","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on April 24, 2019, and is fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on April 24, 2019, and is fully vested."}],"balance_after":0,"derivative":{"exercise_price":6.44,"expiration_date":"2024-04-24","underlying":"Common Shares","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001415889-24-017691","document":"form4-06202024_050614.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1778129/000141588924017691/form4-06202024_050614.xml","form_type":"4"}},{"id":1473264,"issuer":{"id":6184,"kind":"organization","name":"TerrAscend Corp."},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-06-20T21:30:17.000Z","date":"2024-06-17","kind":"grant","planned":false,"acquired":true,"shares":163334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a restricted share unit (\"RSU\") award for service as a director of the Issuer. The shares underlying the RSUs will vest in full on December 31, 2024, subject to the Reporting Person's continuous service with the Issuer as of the vesting date."}],"balance_after":716847,"source":{"system":"sec-edgar","filing":"0001415889-24-017691","document":"form4-06202024_050614.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778129/000141588924017691/form4-06202024_050614.xml","form_type":"4"}},{"id":1538661,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2024-04-19T20:34:56.000Z","date":"2024-01-19","kind":"exercise","planned":false,"acquired":false,"shares":13797,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":206953,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":13797},"source":{"system":"sec-edgar","filing":"0000950170-24-046050","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017024046050/ownership.xml","form_type":"4"}},{"id":1538660,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-04-19T20:34:56.000Z","date":"2024-04-19","kind":"exercise","planned":false,"acquired":true,"shares":13797,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":262793,"source":{"system":"sec-edgar","filing":"0000950170-24-046050","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017024046050/ownership.xml","form_type":"4"}},{"id":1547362,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2024-04-05T19:57:00.000Z","date":"2024-04-03","kind":"exercise","planned":false,"acquired":false,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning one year after the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning one year after the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date."}],"balance_after":187500,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0000950170-24-042226","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017024042226/ownership.xml","form_type":"4"}},{"id":1547361,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-04-05T19:57:00.000Z","date":"2024-04-03","kind":"exercise","planned":false,"acquired":true,"shares":62500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":248996,"source":{"system":"sec-edgar","filing":"0000950170-24-042226","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017024042226/ownership.xml","form_type":"4"}},{"id":1675826,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2024-01-20T01:58:25.000Z","date":"2024-01-19","kind":"grant","planned":false,"acquired":true,"shares":220750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":220750,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":220750},"source":{"system":"sec-edgar","filing":"0001209191-24-001974","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919124001974/doc4.xml","form_type":"4"}},{"id":1675825,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-01-20T01:58:25.000Z","date":"2024-01-19","kind":"grant","planned":false,"acquired":true,"shares":1324502,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant (01/19/2024)."}],"balance_after":1324502,"derivative":{"exercise_price":2.09,"expiration_date":"2034-01-19","underlying":"Common Stock","underlying_shares":1324502},"source":{"system":"sec-edgar","filing":"0001209191-24-001974","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919124001974/doc4.xml","form_type":"4"}},{"id":1737956,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-11-17T17:37:52.000Z","date":"2023-11-16","kind":"purchase","planned":false,"acquired":true,"shares":150000,"price":0.9198,"value":137970.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of purchase prices paid was $0.8888 to $0.94. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased at each separate price."}],"balance_after":186496,"source":{"system":"sec-edgar","filing":"0001209191-23-055664","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123055664/doc4.xml","form_type":"4"}},{"id":1798206,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-08-24T20:09:50.000Z","date":"2023-08-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":692,"price":1.65,"value":1141.8,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to the quarterly vesting of shares from the restricted stock grant made on February 22, 2023."}],"balance_after":36496,"source":{"system":"sec-edgar","filing":"0001209191-23-047180","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123047180/doc4.xml","form_type":"4"}},{"id":1844269,"issuer":{"id":6184,"kind":"organization","name":"TerrAscend Corp."},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-26T18:40:01.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":132647,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent an annual grant of restricted share units (\"RSUs\") for service as a director of the Issuer.  The shares underlying the RSUs will vest in full on December 31, 2023, subject to the Reporting Person's continuous service with the Issuer as of the vesting date."}],"balance_after":553513,"source":{"system":"sec-edgar","filing":"0001209191-23-039624","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778129/000120919123039624/doc4.xml","form_type":"4"}},{"id":1880443,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-05-24T21:04:35.000Z","date":"2023-05-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":691,"price":1.45,"value":1001.95,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to the quarterly vesting of shares from the restricted stock grant made on February 22, 2023."}],"balance_after":37188,"source":{"system":"sec-edgar","filing":"0001209191-23-031910","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123031910/doc4.xml","form_type":"4"}},{"id":1926056,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Performance Stock Option (Right to Buy)","published_at":"2023-04-05T21:10:09.000Z","date":"2023-04-03","kind":"grant","planned":false,"acquired":true,"shares":4250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests and becomes exercisable with respect to escalating portions of the option grant upon the Issuer's stock price reaching certain pre-established levels ranging from $4.50 to $9.00 per share, subject to the Reporting Person's continued service to the Issuer through the vesting date."}],"balance_after":4250000,"derivative":{"exercise_price":1.78,"expiration_date":"2033-04-03","underlying":"Common Stock","underlying_shares":4250000},"source":{"system":"sec-edgar","filing":"0001209191-23-023385","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123023385/doc4.xml","form_type":"4"}},{"id":1926055,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2023-04-05T21:10:09.000Z","date":"2023-04-03","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning one year after the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning one year after the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date."}],"balance_after":250000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001209191-23-023385","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123023385/doc4.xml","form_type":"4"}},{"id":1926054,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-04-05T21:10:09.000Z","date":"2023-04-03","kind":"grant","planned":false,"acquired":true,"shares":3000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable with respect to 750,000 shares on the first anniversary of the date of grant, followed by 2,250,000 shares vesting ratably each month over the subsequent three years, such that 3,000,000 options will be fully vested on the four-year anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date."}],"balance_after":3000000,"derivative":{"exercise_price":1.78,"expiration_date":"2033-04-03","underlying":"Common Stock","underlying_shares":3000000},"source":{"system":"sec-edgar","filing":"0001209191-23-023385","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123023385/doc4.xml","form_type":"4"}},{"id":1972234,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-03-03T14:25:03.000Z","date":"2023-03-02","kind":"disposition_to_issuer","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The option was cancelled pursuant to the Merger Agreement, in exchange for a cash payment equal to (x) the difference between the Merger Consideration and the per share exercise price of the option, multiplied by (y) the number of disposed option shares."}],"balance_after":0,"derivative":{"exercise_price":13.3,"exercise_date":"2022-06-15","expiration_date":"2031-06-14","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001385508-23-000075","document":"wf-form4_167785348993929.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1363558/000138550823000075/wf-form4_167785348993929.xml","form_type":"4"}},{"id":1972233,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-03T14:25:03.000Z","date":"2023-03-02","kind":"disposition_to_issuer","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The option was cancelled pursuant to the Merger Agreement, in exchange for a cash payment equal to (x) the difference between the Merger Consideration and the per share exercise price of the option, multiplied by (y) the number of disposed option shares."}],"balance_after":0,"derivative":{"exercise_price":8.79,"exercise_date":"2021-06-15","expiration_date":"2030-06-15","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001385508-23-000075","document":"wf-form4_167785348993929.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1363558/000138550823000075/wf-form4_167785348993929.xml","form_type":"4"}},{"id":1972232,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-03-03T14:25:03.000Z","date":"2023-03-02","kind":"disposition_to_issuer","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The option was cancelled pursuant to the Merger Agreement, in exchange for a cash payment equal to (x) the difference between the Merger Consideration and the per share exercise price of the option, multiplied by (y) the number of disposed option shares."}],"balance_after":0,"derivative":{"exercise_price":12.75,"exercise_date":"2020-06-12","expiration_date":"2029-06-11","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001385508-23-000075","document":"wf-form4_167785348993929.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1363558/000138550823000075/wf-form4_167785348993929.xml","form_type":"4"}},{"id":1972231,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-03T14:25:03.000Z","date":"2023-03-02","kind":"disposition_to_issuer","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The option was cancelled pursuant to the Merger Agreement, in exchange for a cash payment equal to (x) the difference between the Merger Consideration and the per share exercise price of the option, multiplied by (y) the number of disposed option shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was cancelled pursuant to the Merger Agreement, in exchange for a cash payment equal to (x) the difference between the Merger Consideration and the per share exercise price of the option, multiplied by (y) the number of disposed option shares."}],"balance_after":0,"derivative":{"exercise_price":17.61,"expiration_date":"2028-10-29","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001385508-23-000075","document":"wf-form4_167785348993929.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1363558/000138550823000075/wf-form4_167785348993929.xml","form_type":"4"}},{"id":1972230,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-03T14:25:03.000Z","date":"2023-03-02","kind":"disposition_to_issuer","acquired":false,"shares":2000,"price":20,"value":40000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Disposed of pursuant to the Merger Agreement in exchange for the Merger Consideration. The number of shares disposed of reflects 2,000 shares of Common Stock upon the acceleration of vesting of restricted stock units in accordance with the Merger Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001385508-23-000075","document":"wf-form4_167785348993929.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1363558/000138550823000075/wf-form4_167785348993929.xml","form_type":"4"}},{"id":1972229,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-03T14:25:03.000Z","date":"2023-03-02","kind":"disposition_to_issuer","acquired":false,"shares":53822,"price":20,"value":1076440.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to that certain Agreement and Plan of Merger between the Issuer, Indivior Inc., and Olive Acquisition Subsidiary, Inc., dated as of November 13, 2022 (the \"Merger Agreement\"), in exchange for a cash payment of $20.00 per share without interest thereon (the \"Merger Consideration\")."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001385508-23-000075","document":"wf-form4_167785348993929.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1363558/000138550823000075/wf-form4_167785348993929.xml","form_type":"4"}},{"id":2150564,"issuer":{"id":6184,"kind":"organization","name":"TerrAscend Corp."},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-27T16:00:34.000Z","date":"2022-09-23","kind":"purchase","acquired":true,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction reported was $1.35, and the ranges of prices were between $1.34 and $1.36. Upon request from the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":420866,"source":{"system":"sec-edgar","filing":"0001104659-22-103243","document":"tm2226644-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778129/000110465922103243/tm2226644-2_4seq1.xml","form_type":"4"}},{"id":2151293,"issuer":{"id":6184,"kind":"organization","name":"TerrAscend Corp."},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-26T16:26:42.000Z","date":"2022-09-22","kind":"purchase","acquired":true,"shares":120000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction reported was $1.51, and the ranges of prices were between $1.49 and $1.55. Upon request from the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":360866,"source":{"system":"sec-edgar","filing":"0001104659-22-102917","document":"tm2226644-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778129/000110465922102917/tm2226644-1_4seq1.xml","form_type":"4"}},{"id":2216974,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-07-01T16:37:01.000Z","date":"2022-07-01","kind":"disposition_to_issuer","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the merger agreement between issuer, GlaxoSmithKline plc (\"GSK\") and a subsidiary of GSK, this option was cancelled on the effective date of the merger in exchange for a cash payment equal to, on a per share basis, the offer price of $55.00 less the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option fully vested on June 8, 2022."}],"balance_after":0,"derivative":{"exercise_price":18.11,"expiration_date":"2031-06-08","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-22-040255","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1290149/000120919122040255/doc4.xml","form_type":"4"}},{"id":2216973,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-07-01T16:37:01.000Z","date":"2022-07-01","kind":"disposition_to_issuer","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the merger agreement between issuer, GlaxoSmithKline plc (\"GSK\") and a subsidiary of GSK, this option was cancelled on the effective date of the merger in exchange for a cash payment equal to, on a per share basis, the offer price of $55.00 less the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option fully vested on May 28, 2021."}],"balance_after":0,"derivative":{"exercise_price":13.88,"expiration_date":"2030-05-28","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-22-040255","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1290149/000120919122040255/doc4.xml","form_type":"4"}},{"id":2216972,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-01T16:37:01.000Z","date":"2022-07-01","kind":"disposition_to_issuer","acquired":false,"shares":13500,"price":55,"value":742500.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-040255","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1290149/000120919122040255/doc4.xml","form_type":"4"}},{"id":2219397,"issuer":{"id":6184,"kind":"organization","name":"TerrAscend Corp."},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-30T01:08:01.000Z","date":"2022-06-27","kind":"grant","acquired":true,"shares":77918,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a grant of an equity award that will vest on December 31, 2022."}],"balance_after":240866,"source":{"system":"sec-edgar","filing":"0001104659-22-075927","document":"tm2220111-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1778129/000110465922075927/tm2220111-1_4seq1.xml","form_type":"4"}},{"id":2219396,"issuer":{"id":6184,"kind":"organization","name":"TerrAscend Corp."},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-30T01:08:01.000Z","date":"2022-06-27","kind":"grant","acquired":true,"shares":36496,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of an equity award that vested on the same as the grant, June 27, 2022."}],"balance_after":162948,"source":{"system":"sec-edgar","filing":"0001104659-22-075927","document":"tm2220111-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778129/000110465922075927/tm2220111-1_4seq1.xml","form_type":"4"}},{"id":2232348,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-14T21:00:35.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"2,000 shares are represented by restricted stock units (\"RSUs\"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of Issuer, subject to the vesting schedule: 100% vest on the one year anniversary date or the date of the 2023 Annual Shareholder Meeting, whichever is earlier, subject to the Reporting Person continuing as a service provider through each such date."},{"field":"shares","element":"transactionShares","label":"F1","text":"2,000 shares are represented by restricted stock units (\"RSUs\"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of Issuer, subject to the vesting schedule: 100% vest on the one year anniversary date or the date of the 2023 Annual Shareholder Meeting, whichever is earlier, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":55822,"source":{"system":"sec-edgar","filing":"0001385508-22-000090","document":"wf-form4_165524040681105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1363558/000138550822000090/wf-form4_165524040681105.xml","form_type":"4"}},{"id":2233783,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-13T20:55:35.000Z","date":"2022-06-13","kind":"purchase","acquired":true,"shares":4037,"price":10.936,"value":44148.632,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $10.82 to $10.95. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":53822,"source":{"system":"sec-edgar","filing":"0001385508-22-000076","document":"wf-form4_165515371990084.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1363558/000138550822000076/wf-form4_165515371990084.xml","form_type":"4"}},{"id":2233782,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-13T20:55:35.000Z","date":"2022-06-10","kind":"purchase","acquired":true,"shares":1663,"price":11.496,"value":19117.848,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $11.48 to $11.50. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":49785,"source":{"system":"sec-edgar","filing":"0001385508-22-000076","document":"wf-form4_165515371990084.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1363558/000138550822000076/wf-form4_165515371990084.xml","form_type":"4"}},{"id":2267542,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-17T20:02:13.000Z","date":"2022-05-16","kind":"purchase","acquired":true,"shares":27150,"price":13.54,"value":367611.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $12.10 to $13.99. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":48122,"source":{"system":"sec-edgar","filing":"0001385508-22-000061","document":"wf-form4_165281769689341.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1363558/000138550822000061/wf-form4_165281769689341.xml","form_type":"4"}},{"id":2269909,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-16T20:05:15.000Z","date":"2022-05-13","kind":"purchase","acquired":true,"shares":3689,"price":10.49,"value":38697.61,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $10.47 to $10.50. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":20972,"source":{"system":"sec-edgar","filing":"0001385508-22-000058","document":"wf-form4_165273148149667.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1363558/000138550822000058/wf-form4_165273148149667.xml","form_type":"4"}},{"id":2438962,"issuer":{"id":6184,"kind":"organization","name":"TerrAscend Corp."},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (right to buy)","published_at":"2022-01-11T02:30:12.000Z","date":"2022-01-06","kind":"other","acquired":true,"shares":52939,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":2.54,"exercise_date":"2020-01-10","expiration_date":"2022-01-14","underlying":"Common Shares","underlying_shares":52939},"source":{"system":"sec-edgar","filing":"0001104659-22-002883","document":"tm2129883-13_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1778129/000110465922002883/tm2129883-13_4seq1.xml","form_type":"4"}},{"id":2438961,"issuer":{"id":6184,"kind":"organization","name":"TerrAscend Corp."},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-01-11T02:30:12.000Z","date":"2022-01-06","kind":"other","acquired":true,"shares":52939,"price":2.54,"value":134465.06,"ownership":{"direct":true},"balance_after":126452,"source":{"system":"sec-edgar","filing":"0001104659-22-002883","document":"tm2129883-13_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778129/000110465922002883/tm2129883-13_4seq1.xml","form_type":"4"}},{"id":2495031,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-24T19:07:05.000Z","date":"2021-11-24","kind":"purchase","acquired":true,"shares":7899,"price":23.085,"value":182348.415,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares purchased. These shares were purchased in multiple transactions at prices ranging from $22.645 to $23.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein."}],"balance_after":13500,"source":{"system":"sec-edgar","filing":"0001209191-21-066860","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1290149/000120919121066860/doc4.xml","form_type":"4"}},{"id":2495030,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-24T19:07:05.000Z","date":"2021-11-23","kind":"purchase","acquired":true,"shares":5601,"price":22.945,"value":128514.945,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares purchased. These shares were purchased in multiple transactions at prices ranging from $22.625 to $23.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein."}],"balance_after":5601,"source":{"system":"sec-edgar","filing":"0001209191-21-066860","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1290149/000120919121066860/doc4.xml","form_type":"4"}},{"id":2568773,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-15T20:01:35.000Z","date":"2021-09-13","kind":"grant","acquired":true,"shares":700,"price":18.07,"value":12649.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $18.02 to $18.15. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":17283,"source":{"system":"sec-edgar","filing":"0001385508-21-000131","document":"wf-form4_163173607782364.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1363558/000138550821000131/wf-form4_163173607782364.xml","form_type":"4"}},{"id":2568772,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-15T20:01:35.000Z","date":"2021-09-13","kind":"grant","acquired":true,"shares":506,"price":17.96,"value":9087.76,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $17.94 to $17.97. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":16583,"source":{"system":"sec-edgar","filing":"0001385508-21-000131","document":"wf-form4_163173607782364.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1363558/000138550821000131/wf-form4_163173607782364.xml","form_type":"4"}},{"id":2568771,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-15T20:01:35.000Z","date":"2021-09-13","kind":"purchase","acquired":true,"shares":2500,"price":18.13,"value":45325.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $18.05 to $18.16. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":16077,"source":{"system":"sec-edgar","filing":"0001385508-21-000131","document":"wf-form4_163173607782364.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1363558/000138550821000131/wf-form4_163173607782364.xml","form_type":"4"}},{"id":2571822,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-13T20:08:00.000Z","date":"2021-09-10","kind":"purchase","acquired":true,"shares":9577,"price":18.18,"value":174109.86,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $18.06 to $18.20. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":13577,"source":{"system":"sec-edgar","filing":"0001385508-21-000126","document":"wf-form4_163156366596978.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1363558/000138550821000126/wf-form4_163156366596978.xml","form_type":"4"}},{"id":2665769,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-16T20:01:58.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On June 15, 2021, the reporting person was granted 2,500 non-qualified stock options. 100% of the options vest on the one year anniversary of the grant date or the date of the 2022 Annual Shareholder Meeting, whichever is earlier, subject to the Reporting Person continuing as a service provider through such date."}],"balance_after":2500,"derivative":{"exercise_price":13.3,"exercise_date":"2022-06-15","expiration_date":"2031-06-14","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001385508-21-000083","document":"wf-form4_162387369433080.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1363558/000138550821000083/wf-form4_162387369433080.xml","form_type":"4"}},{"id":2665768,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-16T20:01:58.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"2,000 shares are represented by restricted stock units (\"RSUs\"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of Issuer, subject to the vesting schedule: 100% vest on the one year anniversary date or the date of the 2022 Annual Shareholder Meeting, whichever is earlier, subject to the Reporting Person continuing as a service provider through such date."}],"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001385508-21-000083","document":"wf-form4_162387369433080.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1363558/000138550821000083/wf-form4_162387369433080.xml","form_type":"4"}},{"id":2675424,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right To Buy)","published_at":"2021-06-09T10:50:39.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option fully vests and becomes exercisable on June 8, 2022, subject to the Reporting Person's provision of service to the Issuer as of the vesting date."}],"balance_after":6000,"derivative":{"exercise_price":18.11,"expiration_date":"2031-06-08","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-21-039094","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1290149/000120919121039094/doc4.xml","form_type":"4"}},{"id":3110174,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-15T20:05:06.000Z","date":"2020-06-15","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On June 15, 2020, the Reporting Person was granted 2,500 non-qualified stock options. 100% of the options vest on the one year anniversary of the grant date or the date of the 2021 Annual Shareholder Meeting, whichever is earlier, subject to the Reporting Person continuing as a service provider through such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 15, 2020, the Reporting Person was granted 2,500 non-qualified stock options. 100% of the options vest on the one year anniversary of the grant date or the date of the 2021 Annual Shareholder Meeting, whichever is earlier, subject to the Reporting Person continuing as a service provider through such date."}],"balance_after":2500,"derivative":{"exercise_price":8.79,"exercise_date":"2021-06-15","expiration_date":"2030-06-15","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001385508-20-000071","document":"wf-form4_159225148826104.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1363558/000138550820000071/wf-form4_159225148826104.xml","form_type":"4"}},{"id":3110173,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-15T20:05:06.000Z","date":"2020-06-15","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"2,000 shares are represented by restricted stock units (\"RSUs\"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of Issuer, subject to the vesting schedule: 100% vest on the one year anniversary date or the date of the 2021 Annual Shareholder Meeting, whichever is earlier, subject to the Reporting Person continuing as a service provider through such date."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001385508-20-000071","document":"wf-form4_159225148826104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1363558/000138550820000071/wf-form4_159225148826104.xml","form_type":"4"}},{"id":3130401,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-29T16:32:14.000Z","date":"2020-05-28","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/12 of the total shares monthly, beginning on June 28, 2020, with 100% of the total shares vested and exercisable on May 28, 2021, subject to the Reporting Person's provision of service to the issuer on each vesting date."}],"balance_after":10000,"derivative":{"exercise_price":13.88,"expiration_date":"2030-05-28","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-20-032947","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1290149/000120919120032947/doc4.xml","form_type":"4"}},{"id":3490985,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-13T20:07:00.000Z","date":"2019-06-12","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 12, 2019, the reporting person was granted 2,500 non-qualified stock options. 100% of the options vest on the one year anniversary of the grant date."}],"balance_after":2500,"derivative":{"exercise_price":12.75,"exercise_date":"2020-06-12","expiration_date":"2029-06-11","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001385508-19-000062","document":"wf-form4_156045640489628.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1363558/000138550819000062/wf-form4_156045640489628.xml","form_type":"4"}},{"id":3778898,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-31T20:06:19.000Z","date":"2018-10-29","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On October 29, 2018, the reporting person was granted an option to purchase 5,000 shares of common stock. The options vest as follows: 33% of the options vest on the first, second and third anniversary of the grant date."}],"balance_after":5000,"derivative":{"exercise_price":17.61,"expiration_date":"2028-10-29","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001385508-18-000098","document":"wf-form4_154101636286460.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1363558/000138550818000098/wf-form4_154101636286460.xml","form_type":"4"}}]}